Angola
Tuberculosis profile
| High HIV burden |
Population  2012 21 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 8.7 (3.9–15) 42 (19–73)
Mortality (HIV+TB only) 1.3 (1.1–1.4) 6.1 (5.4–7)
Prevalence  (includes HIV+TB) 99 (48–170) 474 (230–804)
Incidence  (includes HIV+TB) 66 (55–77) 316 (266–369)
Incidence (HIV+TB only) 5.5 (4.7–6.5) 27 (22–31)
Case detection, all forms (%) 79 (67–94)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 21 124 (43) Relapse 2 863 (64)
Smear-negative 21 226 (43) Treatment after failure 635 (14)
Smear-unknown / not done 1 830 (4) Treatment after default 972 (22)
Extrapulmonary 4 776 (10) Other    
Other 0 (0)      
Total new 48 956   Total retreatment 4 470  
           
Other (history unknown)          
Total new and relapse 51 819   Total cases notified 53 426  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.3    
Age < 15 982   2 080
Laboratories 2012
Smear (per 100 000 population) 0.6
Culture (per 5 million population) 0.5
Drug susceptibility testing (per 5 million population) 0.5
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 55   Is rifampicin used
throughout treatment for
new patients?
No
New smear-negative/extrapulmonary 0  
Retreatment 0  
TB/HIV 2012 Number (%)
TB patients with known HIV status 12 022 (23)
HIV-positive TB patients 1 149 (10)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 149 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 1 149 (100)
HIV-positive people screened for TB 11 703  
HIV-positive people provided with IPT 1 100  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.8 (0.1–3.4) 19 (7.4–31)
MDR-TB cases among notified pulmonary
TB cases
800 (44–1 500) 860 (330–1 400)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB   45 (1%) 45
Laboratory-confirmed MDR-TB cases   45 45
Patients started on MDR-TB treatment     45
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-21 Data: www.who.int/tb/data